BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Tanespimycin

a micellar preparation of paclitaxel, rapamycin, and tanespimycin Heading Mapped to: Drug Combinations Benzoquinones Paclitaxel Sirolimus Lactams, Macrocyclic

33+ PubMed studies analyzed · 2 RCTs · Evidence Score: 43.4

Research Domains

Tanespimycin has been studied across 10 research domains including 🔬 Oncology, 🫁 Liver & Detox, 🔥 Metabolic, ⚡ Energy & Fatigue, 🧬 Hormones. The primary research focus is 🔬 Oncology with 70% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Tanespimycin, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

19-((1'S,4'R)-4'-hydroxy-1'-methoxy-2'-oxopentyl)geldanamycin
10 shared targets
Deferasirox
11 shared targets
Trabectedin
11 shared targets
Feprazone
11 shared targets
Thapsigargin
9 shared targets
Proscillaridin
10 shared targets
ag490
10 shared targets
Ethynodiol
12 shared targets
Emetine
15 shared targets
Deslanoside
9 shared targets
Loading evidence profile...

This evidence profile for Tanespimycin is generated deterministically from 33 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.